Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
ECL vs CTAS vs SHW vs UNF vs EMN
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Chemicals - Specialty
Specialty Business Services
Chemicals - Specialty
ECL vs CTAS vs SHW vs UNF vs EMN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Specialty Business Services | Chemicals - Specialty | Specialty Business Services | Chemicals - Specialty |
| Market Cap | $72.46B | $68.52B | $78.98B | $4.76B | $8.43B |
| Revenue (TTM) | $16.08B | $10.79B | $23.94B | $2.45B | $8.64B |
| Net Income (TTM) | $2.08B | $1.90B | $2.60B | $140M | $399M |
| Gross Margin | 44.5% | 50.2% | 49.1% | 36.5% | 19.8% |
| Operating Margin | 17.7% | 23.0% | 16.1% | 7.1% | 9.4% |
| Forward P/E | 30.6x | 34.8x | 27.3x | 36.0x | 12.5x |
| Total Debt | $9.43B | $2.65B | $14.53B | $72M | $5.08B |
| Cash & Equiv. | $646M | $264M | $207M | $204M | $566M |
ECL vs CTAS vs SHW vs UNF vs EMN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ecolab Inc. (ECL) | 100 | 120.7 | +20.7% |
| Cintas Corporation (CTAS) | 100 | 274.3 | +174.3% |
| The Sherwin-William… (SHW) | 100 | 161.8 | +61.8% |
| UniFirst Corporation (UNF) | 100 | 142.6 | +42.6% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECL vs CTAS vs SHW vs UNF vs EMN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECL is the clearest fit if your priority is income & stability.
- Dividend streak 12 yrs, beta 0.63, yield 1.0%
CTAS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 7.7%, EPS growth 16.1%, 3Y rev CAGR 9.6%
- 6.9% 10Y total return vs SHW's 250.0%
- Lower volatility, beta 0.51, Low D/E 56.7%, current ratio 2.09x
- PEG 2.08 vs UNF's 15.82
Among these 5 stocks, SHW doesn't own a clear edge in any measured category.
UNF ranks third and is worth considering specifically for momentum.
- +42.6% vs CTAS's -20.1%
EMN is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (12.5x vs 36.0x), PEG 3.89 vs 15.82
- 4.5% yield, 12-year raise streak, vs SHW's 1.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.7% revenue growth vs EMN's -6.7% | |
| Value | Lower P/E (12.5x vs 36.0x), PEG 3.89 vs 15.82 | |
| Quality / Margins | 17.6% margin vs EMN's 4.6% | |
| Stability / Safety | Beta 0.51 vs EMN's 1.36, lower leverage | |
| Dividends | 4.5% yield, 12-year raise streak, vs SHW's 1.0% | |
| Momentum (1Y) | +42.6% vs CTAS's -20.1% | |
| Efficiency (ROA) | 18.7% ROA vs EMN's 2.6%, ROIC 25.8% vs 6.7% |
ECL vs CTAS vs SHW vs UNF vs EMN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ECL vs CTAS vs SHW vs UNF vs EMN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CTAS leads in 2 of 6 categories
EMN leads 1 • UNF leads 1 • ECL leads 0 • SHW leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CTAS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SHW is the larger business by revenue, generating $23.9B annually — 9.8x UNF's $2.4B. CTAS is the more profitable business, keeping 17.6% of every revenue dollar as net income compared to EMN's 4.6%. On growth, CTAS holds the edge at +9.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $16.1B | $10.8B | $23.9B | $2.4B | $8.6B |
| EBITDAEarnings before interest/tax | $3.5B | $2.9B | $4.5B | $318M | $1.2B |
| Net IncomeAfter-tax profit | $2.1B | $1.9B | $2.6B | $140M | $399M |
| Free Cash FlowCash after capex | $1.9B | $1.8B | $2.9B | $93M | $498M |
| Gross MarginGross profit ÷ Revenue | +44.5% | +50.2% | +49.1% | +36.5% | +19.8% |
| Operating MarginEBIT ÷ Revenue | +17.7% | +23.0% | +16.1% | +7.1% | +9.4% |
| Net MarginNet income ÷ Revenue | +12.9% | +17.6% | +10.9% | +5.7% | +4.6% |
| FCF MarginFCF ÷ Revenue | +11.8% | +16.5% | +12.1% | +3.8% | +5.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.8% | +9.3% | +6.8% | +2.7% | -4.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +19.3% | +11.0% | +7.5% | -18.2% | -40.8% |
Valuation Metrics
EMN leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 18.0x trailing earnings, EMN trades at a 53% valuation discount to CTAS's 38.6x P/E. Adjusting for growth (PEG ratio), CTAS offers better value at 2.31x vs UNF's 14.10x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $72.5B | $68.5B | $79.0B | $4.8B | $8.4B |
| Enterprise ValueMkt cap + debt − cash | $81.2B | $70.9B | $93.3B | $4.6B | $12.9B |
| Trailing P/EPrice ÷ TTM EPS | 35.24x | 38.65x | 31.18x | 32.13x | 17.97x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.64x | 34.75x | 27.27x | 36.05x | 12.50x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.31x | 4.51x | 14.10x | 5.59x |
| EV / EBITDAEnterprise value multiple | 22.66x | 24.85x | 21.24x | 14.17x | 8.96x |
| Price / SalesMarket cap ÷ Revenue | 4.51x | 6.63x | 3.35x | 1.96x | 0.96x |
| Price / BookPrice ÷ Book value/share | 7.46x | 14.89x | 17.33x | 2.20x | 1.41x |
| Price / FCFMarket cap ÷ FCF | 38.05x | 39.00x | 29.76x | 33.70x | 19.87x |
Profitability & Efficiency
CTAS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SHW delivers a 58.2% return on equity — every $100 of shareholder capital generates $58 in annual profit, vs $6 for UNF. UNF carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to SHW's 3.16x. On the Piotroski fundamental quality scale (0–9), CTAS scores 9/9 vs UNF's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +22.0% | +42.6% | +58.2% | +6.5% | +6.7% |
| ROA (TTM)Return on assets | +8.8% | +18.7% | +10.0% | +5.1% | +2.6% |
| ROICReturn on invested capital | +12.7% | +25.8% | +16.5% | +6.8% | +6.7% |
| ROCEReturn on capital employed | +15.8% | +29.8% | +21.3% | +7.4% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 9 | 6 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.96x | 0.57x | 3.16x | 0.03x | 0.84x |
| Net DebtTotal debt minus cash | $8.8B | $2.4B | $14.3B | -$131M | $4.5B |
| Cash & Equiv.Liquid assets | $646M | $264M | $207M | $204M | $566M |
| Total DebtShort + long-term debt | $9.4B | $2.7B | $14.5B | $72M | $5.1B |
| Interest CoverageEBIT ÷ Interest expense | 9.82x | 24.61x | 7.83x | — | 2.22x |
Total Returns (Dividends Reinvested)
UNF leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CTAS five years ago would be worth $19,584 today (with dividends reinvested), compared to $7,163 for EMN. Over the past 12 months, UNF leads with a +42.6% total return vs CTAS's -20.1%. The 3-year compound annual growth rate (CAGR) favors UNF at 17.6% vs EMN's 1.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -2.0% | -7.8% | -2.1% | +32.6% | +15.8% |
| 1-Year ReturnPast 12 months | +2.0% | -20.1% | -8.0% | +42.6% | +2.3% |
| 3-Year ReturnCumulative with dividends | +52.7% | +51.7% | +42.4% | +62.5% | +3.4% |
| 5-Year ReturnCumulative with dividends | +17.3% | +95.8% | +16.1% | +16.5% | -28.4% |
| 10-Year ReturnCumulative with dividends | +139.5% | +685.0% | +250.0% | +140.5% | +35.4% |
| CAGR (3Y)Annualised 3-year return | +15.2% | +14.9% | +12.5% | +17.6% | +1.1% |
Risk & Volatility
Evenly matched — CTAS and UNF each lead in 1 of 2 comparable metrics.
Risk & Volatility
CTAS is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than EMN's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNF currently trades 90.4% from its 52-week high vs CTAS's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.63x | 0.51x | 0.79x | 0.58x | 1.36x |
| 52-Week HighHighest price in past year | $309.27 | $229.24 | $379.65 | $283.77 | $84.18 |
| 52-Week LowLowest price in past year | $249.04 | $165.46 | $301.58 | $147.66 | $56.11 |
| % of 52W HighCurrent price vs 52-week peak | +83.0% | +74.2% | +84.3% | +90.4% | +87.5% |
| RSI (14)Momentum oscillator 0–100 | 46.0 | 37.7 | 47.6 | 47.0 | 56.9 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 2.2M | 1.6M | 328K | 1.5M |
Analyst Outlook
Evenly matched — SHW and EMN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ECL as "Buy", CTAS as "Hold", SHW as "Buy", UNF as "Hold", EMN as "Buy". Consensus price targets imply 31.4% upside for CTAS (target: $223) vs -21.2% for UNF (target: $202). For income investors, EMN offers the higher dividend yield at 4.47% vs UNF's 0.52%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $327.11 | $223.40 | $389.43 | $202.00 | $77.29 |
| # AnalystsCovering analysts | 37 | 30 | 38 | 6 | 35 |
| Dividend YieldAnnual dividend ÷ price | +1.0% | +0.9% | +1.0% | +0.5% | +4.5% |
| Dividend StreakConsecutive years of raises | 12 | 3 | 37 | 9 | 12 |
| Dividend / ShareAnnual DPS | $2.64 | $1.49 | $3.17 | $1.33 | $3.30 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +1.4% | 0.0% | +1.5% | +1.2% |
CTAS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMN leads in 1 (Valuation Metrics). 2 tied.
ECL vs CTAS vs SHW vs UNF vs EMN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ECL or CTAS or SHW or UNF or EMN a better buy right now?
For growth investors, Cintas Corporation (CTAS) is the stronger pick with 7.
7% revenue growth year-over-year, versus -6. 7% for Eastman Chemical Company (EMN). Eastman Chemical Company (EMN) offers the better valuation at 18. 0x trailing P/E (12. 5x forward), making it the more compelling value choice. Analysts rate Ecolab Inc. (ECL) a "Buy" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECL or CTAS or SHW or UNF or EMN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
0x versus Cintas Corporation at 38. 6x. On forward P/E, Eastman Chemical Company is actually cheaper at 12. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cintas Corporation wins at 2. 08x versus UniFirst Corporation's 15. 82x.
03Which is the better long-term investment — ECL or CTAS or SHW or UNF or EMN?
Over the past 5 years, Cintas Corporation (CTAS) delivered a total return of +95.
8%, compared to -28. 4% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: CTAS returned +685. 0% versus EMN's +35. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECL or CTAS or SHW or UNF or EMN?
By beta (market sensitivity over 5 years), Cintas Corporation (CTAS) is the lower-risk stock at 0.
51β versus Eastman Chemical Company's 1. 36β — meaning EMN is approximately 167% more volatile than CTAS relative to the S&P 500. On balance sheet safety, UniFirst Corporation (UNF) carries a lower debt/equity ratio of 3% versus 3% for The Sherwin-Williams Company — giving it more financial flexibility in a downturn.
05Which is growing faster — ECL or CTAS or SHW or UNF or EMN?
By revenue growth (latest reported year), Cintas Corporation (CTAS) is pulling ahead at 7.
7% versus -6. 7% for Eastman Chemical Company (EMN). On earnings-per-share growth, the picture is similar: Cintas Corporation grew EPS 16. 1% year-over-year, compared to -46. 5% for Eastman Chemical Company. Over a 3-year CAGR, CTAS leads at 9. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECL or CTAS or SHW or UNF or EMN?
Cintas Corporation (CTAS) is the more profitable company, earning 17.
5% net margin versus 5. 4% for Eastman Chemical Company — meaning it keeps 17. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CTAS leads at 22. 8% versus 7. 6% for UNF. At the gross margin level — before operating expenses — CTAS leads at 50. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECL or CTAS or SHW or UNF or EMN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Cintas Corporation (CTAS) is the more undervalued stock at a PEG of 2. 08x versus UniFirst Corporation's 15. 82x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Eastman Chemical Company (EMN) trades at 12. 5x forward P/E versus 36. 0x for UniFirst Corporation — 23. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CTAS: 31. 4% to $223. 40.
08Which pays a better dividend — ECL or CTAS or SHW or UNF or EMN?
All stocks in this comparison pay dividends.
Eastman Chemical Company (EMN) offers the highest yield at 4. 5%, versus 0. 5% for UniFirst Corporation (UNF).
09Is ECL or CTAS or SHW or UNF or EMN better for a retirement portfolio?
For long-horizon retirement investors, Cintas Corporation (CTAS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 0. 9% yield, +685. 0% 10Y return). Both have compounded well over 10 years (CTAS: +685. 0%, EMN: +35. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECL and CTAS and SHW and UNF and EMN?
These companies operate in different sectors (ECL (Basic Materials) and CTAS (Industrials) and SHW (Basic Materials) and UNF (Industrials) and EMN (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ECL is a mid-cap quality compounder stock; CTAS is a mid-cap quality compounder stock; SHW is a mid-cap quality compounder stock; UNF is a small-cap quality compounder stock; EMN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.